Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Autolus Therapeutics (AUTL) Shares Issued: 2018-2024

Historic Shares Issued for Autolus Therapeutics (AUTL) over the last 1 years, with Mar 2024 value amounting to $550.0 million.

  • Autolus Therapeutics' Shares Issued was N/A to $550.0 million in Q1 2024 from the same period last year, while for Mar 2024 it was $718.6 million, marking a year-over-year change of. This contributed to the annual value of $550.0 million for FY2024, which is 2036851.85% up from last year.
  • Per Autolus Therapeutics' latest filing, its Shares Issued stood at $550.0 million for Q1 2024, which was up 402.82% from $109.4 million recorded in Q4 2021.
  • Over the past 5 years, Autolus Therapeutics' Shares Issued peaked at $550.0 million during Q1 2024, and registered a low of $29.6 million during Q2 2021.
  • Moreover, its 1-year median value for Shares Issued was $550.0 million (2024), whereas its average is $550.0 million.